Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-04 4:16 pm Purchase | 2024-09-30 | 13G | Recursion Pharmaceuticals, Inc. RXRX | KINNEVIK AB (PUBL) | 11,905,668 4.300% | 1,500,000 (+14.42%) | Filing History |
| 2023-05-22 4:05 pm Purchase | 2023-05-12 | 13G | Recursion Pharmaceuticals, Inc. RXRX | KINNEVIK AB (PUBL) | 10,405,668 5.600% | 10,405,668 (New Position) | Filing History |
| 2022-11-14 06:52 am Purchase | 2022-11-03 | 13D | Babylon Holdings Limited BBLN | KINNEVIK AB (PUBL) | 4,617,341 18.600% | 2,419,638 (+110.10%) | Filing History |
| 2022-05-25 2:30 pm Purchase | 2021-12-31 | 13G | Babylon Holdings Limited BBLN | KINNEVIK AB (PUBL) | 2,197,703 16.600% | 2,197,703 (New Position) | Filing History |
| 2022-02-08 2:13 pm Purchase | 2021-12-31 | 13G | Babylon Holdings Limited BBLN | Invik S.A. | 2,197,703 16.600% | 2,197,703 (New Position) | Filing History |
| 2021-04-15 4:00 pm Unchanged | 2021-03-01 | 13D | Teladoc Health, Inc. TDOC | KINNEVIK AB (PUBL) | 7,491,124 4.910% | 0 (Unchanged) | Filing History |